Press Releases from Alzheimers (1 total)
Development of Alzheimers Therapeutics in Asia-Pacific Markets : Research and Fo …
ALBANY, NY, May 5, 2017 : Alzheimers Disease (AD) is an irreversible, progressive neurodegenerative disease, characterized by cognitive impairment, memory loss and functional decline. Symptoms typically begin to first occur in patients in their mid-sixties, appearing in varying stages. The pathological features of AD comprise histopathological changes within the brain. Mild Cognitive Impairment (MCI) is a heterogeneous condition between normal cognition and dementia, whereby cognitive changes in mental abilities, such…
